Jonathan Fox, M.D., Ph.D.
President and Chief Medical Officer
Jonathan Fox, M.D., Ph.D., is president and chief medical officer of Eidos Therapeutics. He is an experienced pharmaceutical executive and established industry leader. Before joining Eidos, he was chief medical officer for MyoKardia Inc., and held senior roles with AstraZeneca, Merck and GlaxoSmithKline. With nearly 20 years’ experience across all clinical and regulatory phases of drug development, he has participated in the development, registration, and post-marketing support of numerous products for heritable cardiomyopathies, acute coronary syndrome, heart failure, hypertension, dyslipidemias, arrhythmias, diabetes, and other disorders.
Dr. Fox is a board-certified cardiologist with basic science training and experience. He received his A.B., Ph.D., and M.D. degrees from the University of Chicago, completed his training in Internal Medicine and Cardiology at Duke University, and was on the faculty of the University of Pennsylvania School of Medicine. Dr. Fox is currently adjunct professor at Stanford University School of Medicine and is a long-serving Trustee of the Lankenau Institute for Medical Research. He enjoys living in San Francisco and being part of the vibrant Bay Area medical and biotechnology community.